Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine

Chiron Corporation

Status and phase

Unknown

Phase 4

Conditions

Meningococcal Disease; Meningococcal Meningitis

Treatments

Biological: · Meningococcal C conjugate vaccine; Meningococcal A/C Polysaccharide vaccine (partial dose)

Study type

Interventional

Funder types

Industry

Identifiers

NCT00262015

M14P2

Details and patient eligibility

About

The purpose of this study is to determine when a memory immune response after re-vaccination with Meningococcal C conjugate vaccine (Menjugate) or challenge with Meningococcal A/C polysaccharide vaccine can be observed, after initial vaccination with Meningococcal C conjugate vaccine during the UK immunization campaign

Sex

All

Ages

13 to 15 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Healthy adolescents between and including 13-15 years of age, who provide written informed consent and who received one immunization with Chiron Meningococcal C Conjugate vaccine (Menjugate) during the UK immunization campaign and for which documentation can be provided.

Exclusion criteria

Subjects with a previous or suspected disease caused by N. meningitidis; or previous immunization with a meningococcal vaccine or vaccine containing meningococcal antigen(s); Any serious acute, chronic or progressive disease